Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor.

Explore this paper's citation graph

Summary

It is proposed that a significant portion of ERBB2's effects on ER+ breast tumors may involve ER-independent mechanisms of gene activation, which may contribute to the clinically aggressive behavior of the 'low-confidence' breast tumor subtype.

Type
article
Published
2003-12-15
Cited by
51
References
31
Access
Open access

Keywords

Estrogen receptor, Breast cancer, Confidence interval, Biology, Estrogen

References

Cited by

Related papers